Triazolam Tablet
Product Images NDC 70771-1576

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 70771-1576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.125 mg Label (D38f9207 Dcd6 46ef B9e9 9d02463ef1ba 01)

This is a medication package for Triazolam, a drug used to treat insomnia. Each tablet contains 0.125 mg of Tiazolam, USP. The package size is not available. Patients are advised to follow the usual dosage instructions mentioned in the package. The tablets are manufactured by Cadila Healthcare Ltd. Users are cautioned to keep the medicine and its package out of the reach of children. The medication guide is available on the manufacturer's website. For more information, users can contact Zydus, RxOnly.*

FDA Label Image

0.25 mg Label (D38f9207 Dcd6 46ef B9e9 9d02463ef1ba 02)

Each tablet in this package contains 0.25g of USP Rizzoam. The usual dosage information is not available. The package is intended for Triazolam use. The tablets can be stored at a temperature of 20°C to 25°C and between 15°C and 30°C. The medication should be dispensed by a doctor to patients with a prescription. A medication guide is available and can be provided to the patient by the pharmacist. The product is manufactured by Zydus and is available by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.